Taika Capital’s Elevance Health ELV Stock Holding History

Taika Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,130	Closed	-$3.98M	–	47
2023 Q3	$3.98M	Buy	9,130 +5,630	+161%	+$2.55M	1.89%	26
2023 Q2	$1.56M	Buy	+3,500	New	+$1.61M	0.82%	36

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Taika Capital's ELV Position: Q4 2023 in Review

Taika Capital sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 9,130 shares — an estimated $3.98M sold.

Taika Capital first reported a position in ELV in Q2 2023 and held it in 2 quarters. The position peaked at $3.98M in Q3 2023. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

Taika Capital reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
Taika Capital sold 9,130 Elevance Health shares in Q4 2023, an estimated $3.98M.
Taika Capital first reported a position in Elevance Health in Q2 2023 and held it in 2 quarters.
Taika Capital's Elevance Health position peaked at $3.98M in Q3 2023.
1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Taika Capital's 13F filing for Q4 2023, filed 14 Feb 2024.